These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 18820598

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Advances in adjuvant hormonal therapy for postmenopausal women.
    Strasser-Weippl K, Goss PE.
    J Clin Oncol; 2005 Mar 10; 23(8):1751-9. PubMed ID: 15755983
    [No Abstract] [Full Text] [Related]

  • 3. Commentary: optimal adjuvant endocrine therapy of postmenopausal breast cancer.
    Cunnick G, Mokbel K.
    Int J Fertil Womens Med; 2005 Mar 10; 50(5 Pt 1):197-8. PubMed ID: 16468468
    [Abstract] [Full Text] [Related]

  • 4. [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].
    Tuxen MK, Nielsen DL, Lindberg H, Kamby C.
    Ugeskr Laeger; 2007 Jan 22; 169(4):297-9. PubMed ID: 17274922
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Hormone therapy in breast cancer: the end of tamoxifen?].
    Delozier T.
    Bull Cancer; 2005 Feb 22; 92(2):142-50. PubMed ID: 15749643
    [Abstract] [Full Text] [Related]

  • 9. Adjuvant endocrine treatment of early breast cancer.
    Lønning PE.
    Hematol Oncol Clin North Am; 2007 Apr 22; 21(2):223-38. PubMed ID: 17512446
    [Abstract] [Full Text] [Related]

  • 10. [For postmenopausal women with hormone-dependent tumors. Aromatase inhibitors are the new gold standard].
    Jonat W.
    MMW Fortschr Med; 2006 Mar 23; 148(12):10. PubMed ID: 16625996
    [No Abstract] [Full Text] [Related]

  • 11. Adjuvant endocrine therapy in premenopausal women with breast cancer.
    González Martín A, de la Cruz S, Márquez R.
    Breast Cancer Res Treat; 2010 Sep 23; 123 Suppl 1():43-7. PubMed ID: 20711666
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice.
    Sánchez-Muñoz A, Ribelles N, Márquez A, Pérez-Ruiz E, Alba E.
    J Clin Oncol; 2009 Dec 10; 27(35):e255-6; author reply e257-8. PubMed ID: 19884520
    [No Abstract] [Full Text] [Related]

  • 17. Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: a review of the evidence.
    Litsas G.
    Oncol Nurs Forum; 2008 Jul 10; 35(4):714-21. PubMed ID: 18591176
    [Abstract] [Full Text] [Related]

  • 18. Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer.
    Toi M, Yamashiro H, Tsuji W.
    Breast Cancer; 2009 Jul 10; 16(3):207-18. PubMed ID: 19259765
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.